PI
DYN icon

PEAK6 Investments’s Dyne Therapeutics DYN Stock Holding History

PEAK6 Investments’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$374K Sell
10,400
-5,000
-32% -$199K ﹤0.01% 2481
2024
Q2 		$543K Buy
+15,400
New +$448K ﹤0.01% 2199

Other funds holding DYN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

PEAK6 Investments's DYN Position: Q3 2024 in Review

PEAK6 Investments reduced its Dyne Therapeutics (DYN) stake by 32% in Q3 2024, selling an estimated $199K and leaving 10,400 shares worth $374K. The position accounts for ﹤0.01% of the portfolio, ranked #2481.

PEAK6 Investments first reported a position in DYN in Q2 2024 and has held it in 2 quarters since. The position peaked at $543K in Q2 2024. 200 funds tracked by Wall St. Rank hold DYN as of Q3 2024.

  • PEAK6 Investments held 10,400 shares of Dyne Therapeutics worth $374K as of Q3 2024.
  • PEAK6 Investments sold 5,000 Dyne Therapeutics shares in Q3 2024, an estimated $199K.
  • Dyne Therapeutics made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2481 holding.
  • PEAK6 Investments first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 2 quarters since.
  • PEAK6 Investments's Dyne Therapeutics position peaked at $543K in Q2 2024.
  • 200 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.